Poseida Therapeutics Inc
(FRA:2RZ)
€
2.662
-0.006 (-0.22%)
Market Cap: 267.27 Mil
Enterprise Value: 161.74 Mil
PE Ratio: 0
PB Ratio: 3.41
GF Score: 34/100 Poseida Therapeutics Inc (FRA:2RZ) Transcripts
- Poseida Therapeutics Inc P-BCMA-ALLO1 Clinical Data Call TranscriptDec 10, 2023
- Poseida Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Poseida Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Poseida Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Poseida Therapeutics Inc at HC Wainwright Cell Therapy Virtual Conference TranscriptFeb 28, 2023
- Poseida Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Poseida Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 16, 2022
- Poseida Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Poseida Therapeutics Inc Collaboration and Poseida's Novel Approach to Allogeneic Cell Therapy - Corporate Call TranscriptAug 03, 2022
- Poseida Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- 1